c ebpβ-lip drug C/EBPβ-LIP induces cancer-type metabolic reprogramming by regulating the let-7/LIN28B circuit in mice c ebpβ-lip drug Facts Continuous
c ebp lip drug Facts Continuous Activation of C EBP Transcription Transcriptional Control of COX 2 via C EBP Arteriosclerosis, Thrombosis, and Vascular Biology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect Frontiers C EBP as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



